Jun
2026
Shanghai New International Expo Center
Visit us
stand W1G02, Pharma Ingredients
Zone
Nanjing Lifenergy R&D Co., Ltd.
Exhibitor at CPHI & PMEC China 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand W1G02, Pharma Ingredients
Products Featured at CPHI & PMEC China 2026
-
Product Iron Sucrose Injection
Ferrofer (Iron Sucrose Injection) is indicated for parenteral treatment of iron deficiency in cases whereby oral iron preparations cannot provide for sufficient supplementation.
-
Product Amphotericin B Liposome for Injection
Indications:
Empirical therapy for presumed fungal infection in febrile, neutropenic patients;
Treatment of cryptococcal meningitis in HIV-infected patients;
Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections and treatment of visceral leishm... -
Product Doxorubicin Hydrochloride Liposome Injection
Indications:
Ovarian Cancer
Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy.
Multiple Myeloma
... -
Product Fluximem(phloroglucinol injection)
Nanjing lifenergy r&d co ltd manufactures high quality apis and formulations which includes fluximem(phloroglucinol injection). It belongs to finished products category. Packing: 6 amps/box. It is indicated for symptomatic treatment of the acute pains related to the functional disorders of the digestiv... -
Product Ketobest(compound a- ketoacid tablets)
Nanjing lifenergy r&d co ltd manufactures high quality apis and formulations which includes ketobest(compound ?- ketoacid tablets). It belongs to finished products category. Packing: 100 tablets/box. It is for prevention and therapy of damages due to faulty or deficient protein metabolism in chronic re...




